NCT02537054View on ClinicalTrials.gov

Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 2, 2018

Study Completion Date

July 2, 2018

Conditions
Pseudoxanthoma Elasticum
Interventions
DRUG

Aflibercept

Intravitreal injection

Trial Locations (1)

53127

Department of Ophthalmology, Universtiy of Bonn, Bonn

All Listed Sponsors
lead

University Hospital, Bonn

OTHER

NCT02537054 - Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE) | Biotech Hunter | Biotech Hunter